Atlas Trials

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Clinical trial NCT07428044 · RECRUITING

Trial details

NCT number
NCT07428044
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung CancerNon-small Cell Lung Cancer Stage IINon-Small Cell Lung Cancer Stage IIIANon-Small Cell Lung Cancer Stage IIIB
Start date
2026-02-13
Primary completion
2027-02-13
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.